Home / News Update  / OMRON Healthcare India and AliveCor partner to empower people to fight heart disease at home with portable ECG & Atrial Fibrillation (Afib) monitoring devices

OMRON Healthcare India and AliveCor partner to empower people to fight heart disease at home with portable ECG & Atrial Fibrillation (Afib) monitoring devices

New Delhi, India, May 09, 2024: OMRON Healthcare India, the Indian arm of the Japanese global leader in medical equipment for home health monitoring and treatment, has announced its collaboration with AliveCor India, the Indian

New Delhi, India, May 09, 2024: OMRON Healthcare India, the Indian arm of the Japanese global leader in medical equipment for home health monitoring and treatment, has announced its collaboration with AliveCor India, the Indian subsidiary of the global leader in FDA-cleared, CE marked and CDSCO approved personal electrocardiogram (ECG) technology. With this partnership, OMRON Healthcare India now offers AI-based handheld ECG technology besides being a top blood pressure monitor player in India.

This collaboration, marking a significant milestone in OMRON’s  “Going for Zero” vision to enhance cardiovascular health awareness and prevent incidents, brings forth devices including the first home BPM+ECG Monitoring FDA cleared Device (blood pressure monitor with AliveCor ECG capability in a single device) for early CVD (CardioVascular Disease) detection and management and AliveCor’s FDA-cleared world’s most clinically-validated and pocket-sized personal ECGs. These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more.

OMRON Healthcare has been at the forefront of hypertension management for almost half a century, pioneering innovative solutions to tackle this silent threat. However, as time has advanced, OMRON has come to realize the necessity of expanding its scope beyond hypertension. With a deeper dive into cardiovascular health, the company has unearthed the crucial role of Afib as a significant contributor to stroke and cardiovascular disease risk. Furthermore, hypertension is one of the leading risk factors for the development of AFib.

Afib disrupts the normal heartbeat and causes small & irregular vibrations in the heart,     leading to the collection of blood inside. This can create a clot in the heart, which can travel to the brain, and cause a stroke.Stroke risk is 3.4 times higher with hypertension, but it is 5 times higher with Afib, and so if people frequently have Afib, they may face a stroke shortly. This signifies that monitoring both ECG and blood pressure at home and keeping the doctor informed is crucial for the early management of cardiovascular and cerebrovascular health conditions like stroke, “says Tetsuya Yamada, Managing Director, OMRON Healthcare India.

 

medgatetoday@gmail.com

Review overview
NO COMMENTS

POST A COMMENT